Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05794997 · ClinicalTrials.gov registry record

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Propranolol/Carvedilol Versus Atenolol/Bisoprolol/Sotalol

A clinical trial of Hypertension, sponsored by Brigham and Women's Hospital.

Completed
Registry status
817,337
Enrollment target
1
Study location

NCT05794997 is a study of Hypertension that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 817,337 participants, above the 1,768-participant average among 470 other Hypertension trials with a reported enrollment target (46129% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05794997, a study of Hypertension, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
817,337 participants
Enrollment target
1
Study location

Study Summary

This study aims to evaluate the comparative risk of dementia/Alzheimer's disease onset between patients treated with medications that target specific metabolic pathways and patients treated with alternative medications for the same indication.

Conditions Studied

Interventions

  • DRUG Propranolol or Carvedilol
  • DRUG Atenolol, Bisoprolol or Sotalol

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 817,337 participants
Start Date 2022-11-30
Est. Completion 2023-12-31

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT05794997

The ClinicalTrials.gov registry entry for NCT05794997 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 817,337 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,768-participant average among 470 other Hypertension trials with a reported enrollment target (46129% higher). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Propranolol or Carvedilol is the first listed.

NCT05794997 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05794997 about?

NCT05794997 is a clinical study titled "Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Propranolol/Carvedilol Versus Atenolol/Bisoprolol/Sotalol". This study aims to evaluate the comparative risk of dementia/Alzheimer's disease onset between patients treated with medications that target specific metabolic pathways and patients treated with alternative medications for the same indication.

What is the current status of trial NCT05794997?

This trial is currently completed. The enrollment target is 817,337 participants. The study started on 2022-11-30. Estimated completion is 2023-12-31.

What conditions does trial NCT05794997 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT05794997?

The interventions under investigation include: Propranolol or Carvedilol (DRUG), Atenolol, Bisoprolol or Sotalol (DRUG).

Who is sponsoring clinical trial NCT05794997?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05794997 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.